| dc.contributor.author | Rand, K. | |
| dc.contributor.author | Ramos-Goñi, J. M. | |
| dc.contributor.author | Akmaz, B. | |
| dc.contributor.author | Solé-Feu, L. | |
| dc.contributor.author | Armario Hita, José Carlos | |
| dc.contributor.other | Medicina | es_ES |
| dc.date.accessioned | 2024-06-26T11:29:16Z | |
| dc.date.available | 2024-06-26T11:29:16Z | |
| dc.date.issued | 2024-03-05 | |
| dc.identifier.issn | 2190-9172 | |
| dc.identifier.issn | 2193-8210 | |
| dc.identifier.uri | http://hdl.handle.net/10498/32774 | |
| dc.description.abstract | Letter | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Adis | es_ES |
| dc.rights | Attribution-NonCommercial 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
| dc.source | Dermatology and Therapy | es_ES |
| dc.title | Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’” | es_ES |
| dc.type | other | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | https://doi.org/10.1007/s13555-024-01106-2 | |
| dc.type.hasVersion | VoR | es_ES |